Mechanistic investigation indicated that RAB3A knockdown induced BAG6-EP300 transport to the nucleus, increasing the acetylation of p53 and Rb and inhibiting NSCLC cell proliferation and clonal growth. Here, EP300 is linked to non-small cell lung carcinoma.